# SYRA (Syra Health Corp.) - SEC EDGAR Financial Statements

> Syra Health Corp. reported $8.96M in revenue and net income of $701K for the trailing twelve months ended September 30, 2026 (up 51.5% year over year), with a 42.6% gross margin and a 6.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/SYRA
- Markdown: https://convexityos.com/fundamentals/SYRA.md
- SEC CIK: 0001922335
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:07 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001922335&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $8.96M | +51.5% YoY |
| Operating Income | TTM | $607K | 6.8% margin |
| Net Income | TTM | $701K | 7.8% net margin |
| Diluted EPS | TTM | $0.05 | Split-adjusted |
| Free Cash Flow | TTM | -$448K | -5.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $2.38M | Total debt: $57K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | $7.23M | $7.98M | $5.52M | $5.62M |
| Cost of Revenue | $4.74M | $6.33M | $4.10M | $4.56M |
| **Gross Profit** | $2.49M | $1.65M | $1.41M | $1.06M |
| Research & Development | $68K | $585K | $240K | -- |
| Selling, General & Admin | $1.07M | $1.45M | $1.13M | $576K |
| Total Operating Expenses | $3.39M | $5.42M | $4.30M | $3.15M |
| **Operating Income** | -$904K | -$3.76M | -$2.89M | -$2.09M |
| **EBITDA** | -$884K | -$3.70M | -$2.84M | -$2.07M |
| Interest Income | $21K | $21K | $2.9K | $63 |
| Interest Expense | $13K | $16K | $54K | $29K |
| **Net Income** | -$896K | -$3.76M | -$2.94M | -$2.12M |
| Basic EPS | -$0.08 | -$0.50 | -$0.60 | -$0.70 |
| **Diluted EPS** | -$0.08 | -$0.50 | -$0.60 | -$0.70 |
| Basic Shares Outstanding | 11.9M | 7.6M | 4.9M | 3.0M |
| Diluted Shares Outstanding | 11.9M | 7.6M | 4.9M | 3.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.56M | $2.39M | $2.27M | $1.73M | $1.69M | $1.95M | $1.86M | $2.01M |
| Cost of Revenue | $1.37M | $1.33M | $1.30M | $1.14M | $1.13M | $1.19M | $1.27M | $1.67M |
| **Gross Profit** | $1.19M | $1.07M | $971K | $591K | $555K | $753K | $589K | $335K |
| Research & Development | $47K | $47K | $6.9K | $139 | $816 | $30K | $37K | -$5.1K |
| Selling, General & Admin | $222K | $236K | $213K | $237K | $252K | $289K | $287K | $178K |
| Total Operating Expenses | $885K | $815K | $780K | $727K | $787K | $816K | $1.06M | $837K |
| **Operating Income** | $300K | $252K | $191K | -$136K | -$232K | -$63K | -$473K | -$502K |
| **EBITDA** | $301K | $252K | $192K | -$133K | -$227K | -$57K | -$467K | -$494K |
| Interest Income | $1.0K | $888 | $52K | $5.4K | $8.2K | $3.4K | $4.3K | $2.8K |
| Interest Expense | $1.4K | $2.2K | $2.5K | $4.3K | $1.9K | $3.9K | $3.2K | $5.5K |
| Income Before Tax | $300K | -- | -- | -- | -$226K | -- | -- | -- |
| Income Tax Expense | -$45K | -- | -- | -- | -- | -- | -- | -- |
| **Net Income** | $345K | $250K | $241K | -$135K | -$226K | -$64K | -$472K | -$504K |
| Basic EPS | $0.02 | $0.02 | $0.02 | -- | -$0.02 | -$0.01 | -$0.04 | -- |
| **Diluted EPS** | $0.02 | $0.02 | $0.02 | -- | -$0.02 | -$0.01 | -$0.04 | -- |
| Basic Shares Outstanding | 14.2M | 13.2M | 11.9M | -- | 11.9M | 11.9M | 11.6M | -- |
| Diluted Shares Outstanding | 15.1M | 13.6M | 12.8M | -- | 11.9M | 11.9M | 11.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.61M | $2.40M | $3.28M | $3.3K |
| **Cash & Short-Term Investments** | $1.61M | $2.40M | $3.28M | $3.3K |
| Accounts Receivable, Net | $918K | $681K | $5.5K | $1.20M |
| Other Current Assets | $205K | $277K | $390K | $222K |
| **Total Current Assets** | $2.74M | $3.35M | $4.78M | $1.43M |
| Property, Plant & Equipment, Net | $7.0K | $27K | $79K | $112K |
| **Total Non-Current Assets** | $34K | $327K | $142K | $893K |
| **Total Assets** | $2.77M | $3.68M | $4.92M | $2.32M |
| Accounts Payable | -- | $102K | $463K | -- |
| Deferred Revenue (Current) | $17K | $17K | -- | -- |
| **Total Current Liabilities** | $675K | $614K | $910K | $1.55M |
| **Total Non-Current Liabilities** | $0 | $187K | $0 | $63K |
| **Total Liabilities** | $675K | $801K | $910K | $1.61M |
| **Total Debt (incl. Leases)** | $27K | $299K | $63K | $184K |
| Retained Earnings | -$9.72M | -$8.82M | -$5.06M | -$2.13M |
| **Total Stockholders' Equity** | $2.10M | $2.88M | $4.01M | $710K |
| Total Equity | $2.10M | $2.88M | $4.01M | $710K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.38M | $2.12M | $2.92M | $1.61M | $1.98M | $2.31M | $2.49M | $2.40M |
| **Cash & Short-Term Investments** | $2.38M | $2.12M | $2.92M | $1.61M | $1.98M | $2.31M | $2.49M | $2.40M |
| Accounts Receivable, Net | $1.52M | $1.47M | $869K | $918K | $926K | $886K | -- | $681K |
| Other Current Assets | $263K | $153K | $136K | $205K | $308K | $242K | $211K | $277K |
| **Total Current Assets** | $4.16M | $3.75M | $3.93M | $2.74M | $3.21M | $3.43M | $3.65M | $3.35M |
| Property, Plant & Equipment, Net | $4.5K | $5.2K | $5.9K | $7.0K | $9.2K | $15K | $21K | $27K |
| **Total Non-Current Assets** | $61K | $83K | $17K | $34K | $53K | $37K | $75K | $327K |
| **Total Assets** | $4.23M | $3.83M | $3.94M | $2.77M | $3.26M | $3.47M | $3.72M | $3.68M |
| Accounts Payable | -- | -- | -- | -- | -- | $557K | $325K | $102K |
| Deferred Revenue (Current) | $261K | $506K | $751K | $17K | $142K | $267K | $599K | $17K |
| **Total Current Liabilities** | $1.20M | $1.20M | $1.58M | $675K | $1.05M | $1.06M | $1.27M | $614K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $187K |
| **Total Liabilities** | $1.20M | $1.20M | $1.58M | $675K | $1.05M | $1.06M | $1.27M | $801K |
| **Total Debt (incl. Leases)** | $57K | $78K | $11K | $27K | $43K | $22K | $55K | $299K |
| Retained Earnings | -$8.88M | -$9.23M | -$9.48M | -$9.72M | -$9.59M | -$9.36M | -$9.30M | -$8.82M |
| **Total Stockholders' Equity** | $3.02M | $2.63M | $2.36M | $2.10M | $2.21M | $2.41M | $2.46M | $2.88M |
| Total Equity | $3.02M | $2.63M | $2.36M | $2.10M | $2.21M | $2.41M | $2.46M | $2.88M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$896K | -$3.76M | -$2.94M | -$2.12M |
| Depreciation & Amortization | $20K | $63K | $49K | $15K |
| Stock-Based Compensation | $99K | $60K | $33K | $2.9K |
| Change in Receivables | -$238K | $380K | -$60K | -$940K |
| Change in Payables | $146K | -$361K | $31K | $392K |
| **Operating Cash Flow** | -$448K | -$2.93M | -$2.76M | -$2.24M |
| Capital Expenditure | -$107 | -$11K | -$15K | -$121K |
| **Free Cash Flow** | -$448K | -$2.94M | -$2.77M | -$2.37M |
| **Investing Cash Flow** | -$107 | -$11K | -$15K | -$121K |
| Common Stock Issued | $15K | $2.47M | $5.33M | $2.32M |
| **Financing Cash Flow** | -$333K | $2.06M | $6.05M | $2.27M |
| **Net Change in Cash** | -$781K | -$885K | $3.28M | -$97K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $345K | $250K | $241K | -$135K | -$226K | -$64K | -$472K | -$504K |
| Depreciation & Amortization | $715 | $741 | $1.1K | $2.3K | $5.4K | $6.0K | $6.8K | $7.3K |
| Stock-Based Compensation | $45K | $21K | $23K | $23K | $21K | $21K | $33K | $31K |
| Change in Receivables | -$47K | -$601K | $49K | $7.9K | -$40K | $59K | -$265K | $204K |
| Change in Payables | $16K | -$171K | $119K | -$70K | -$240K | $232K | $223K | -$111K |
| **Operating Cash Flow** | $332K | -$719K | $1.36M | -$289K | -$244K | -$72K | $158K | -$215K |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$215K |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $0 |
| Common Stock Issued | -- | -- | -- | $0 | $0 | $0 | $15K | -- |
| **Financing Cash Flow** | -$72K | -$80K | -$54K | -$73K | -$85K | -$112K | -$63K | -$87K |
| **Net Change in Cash** | $260K | -$799K | $1.31M | -$362K | -$329K | -$185K | $95K | -$302K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Gross Margin** | 34.4% | 20.7% | 25.6% | 18.9% |
| **Operating Margin** | -12.5% | -47.2% | -52.4% | -37.2% |
| **Net Profit Margin** | -12.4% | -47.1% | -53.3% | -37.7% |
| Return on Equity (ROE) | -42.7% | -130.6% | -73.2% | -298.3% |
| Return on Assets (ROA) | -32.3% | -102.2% | -59.7% | -91.3% |
| Current Ratio | 4.06x | 5.46x | 5.25x | 0.92x |
| Quick Ratio | 3.75x | 5.01x | 3.61x | 0.78x |
| Debt to Equity | 0.01x | 0.10x | 0.02x | 0.26x |
| **Revenue Growth (YoY)** | -9.5% | +44.7% | -1.8% | -- |
| Gross Profit Growth (YoY) | +50.5% | +17.1% | +33.0% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 42.6% | 39.3% | 37.6% | 34.4% | 29.8% | 29.1% | 24.0% | 20.7% |
| **Operating Margin** | 6.8% | 0.9% | -3.1% | -12.5% | -16.9% | -18.2% | -34.6% | -47.2% |
| **Net Profit Margin** | 7.8% | 1.6% | -2.4% | -12.4% | -16.9% | -18.1% | -34.4% | -47.1% |
| Return on Equity (ROE) | 23.2% | 5.0% | -7.7% | -42.7% | -57.3% | -60.4% | -113.3% | -130.6% |
| Return on Assets (ROA) | 16.6% | 3.4% | -4.6% | -32.3% | -38.8% | -42.0% | -74.8% | -102.2% |
| Current Ratio | 3.47x | 3.13x | 2.48x | 4.06x | 3.05x | 3.25x | 2.88x | 5.46x |
| Quick Ratio | 3.25x | 3.00x | 2.40x | 3.75x | 2.75x | 3.02x | 1.97x | 5.01x |
| Debt to Equity | 0.02x | 0.03x | 0.00x | 0.01x | 0.02x | 0.01x | 0.02x | 0.10x |
| **Revenue Growth (YoY)** | +51.5% | +23.0% | +22.4% | -13.6% | -25.1% | -1.2% | +6.0% | +13.6% |
| Gross Profit Growth (YoY) | +113.7% | +41.6% | +64.9% | +76.5% | -17.0% | +115.1% | +96.5% | -42.5% |
| Operating Cash Flow Growth (YoY) | -- | -- | +760.7% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
